Trial Profile
A prospective and multicenter trial of intravenous immunoglobulin therapy for idiopathic pulmonary fibrosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 May 2016
Price :
$35
*
At a glance
- Drugs Immune globulin (Primary)
- Indications Idiopathic pulmonary fibrosis; Infections
- Focus Therapeutic Use
- 29 May 2014 New trial record